Clinical Trial Update: A Clinical Trial to Evaluate the Safety and Efficacy of ADX-629 in in Subjects With Elevated Ethanol Levels [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trials evaluated the safety and efficacy of ADX-629 in subjects with elevated ethanol levels. Results were posted February 28, 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ethanol Intoxication

Drugs mentioned

• ADX-629 (ADX-629)

Snippet

Sponsor: Aldeyra Therapeutics, Inc. | Conditions: Ethanol Intoxication | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-02-28